Bad Soden-salmã¼nster, Germany

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Condition: COVID-19 Treatment: Fostamatinib / Placebo Clinical Study Identifier: NCT04629703